KaliVir Immunotherapeutics | RoundOS

Weekly digest by email

Loading companies…

KaliVir Immunotherapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Aug 19, 2026	Series A	$14M	Company K Partners — Role not disclosedFlexus Partners — Role not disclosedNextrans — Role not disclosedQuad Investment Management — Role not disclosedSV Investment — Role not disclosed

Investors

Company K PartnersSeries A Flexus PartnersSeries A NextransSeries A Quad Investment ManagementSeries A SV InvestmentSeries A

Coverage

Aug 19, 2026KaliVir Immunotherapeutics · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

kalivir.com ↗